キャタレント・ジャパン List of News Articles

Packaging can have a significant impact on the success of clinical trials. Please check our EBOOK for important considerations in optimizing packaging.

We are explaining how to simplify and accelerate clinical supply for both domestic and global markets by utilizing Caterpillar's facilities located in mainland China and free trade zones. Please see the details and application button below.

Caterant will open a new facility in Shiga Prefecture in September 2021. This facility offers end-to-end services, including primary packaging, secondary packaging, storage and delivery of clinical trial drugs, and collection and disposal. For more details, please check the related links below.

Please check the EBOOK for the top-class procurement strategy of contrast agents from Catalent, which will make a decisive difference in whether the exam can start as scheduled or be delayed.

In September 2021, we will open a new facility in Japan. This facility will serve as a base to provide integrated clinical supply solutions for oral medications, biologics, and advanced therapeutic products to both global and local sponsors. Please check the following link to see how important it is for providers with localized expertise, like ours, to ensure reliable clinical supply to patients in the APAC region.

In the second half of 2021, we will open a new clinical supply facility in California. This facility is located near our oral dosage development center, and for our sponsors, there is the advantage of shortening the time from product development to clinical supply and market launch by collaborating with a single supplier. We are providing more details in a webinar, so please take a look.

A new storage capability of -20°C to -80°C will be available at the clinical supply facility in Singapore. With the acquisition of import/re-export licenses and enhanced cold chain handling and distribution facilities, this hub is an excellent option for sponsors seeking advanced clinical supply in the APAC region.

This webinar will explain the regulations and best practices regarding the supply of investigational drugs in domestic clinical trials, as well as the importance of regional expertise and other fundamental aspects. A Global Sponsor’s Guide to Successful Clinical Supply in Japan Presented by: Nakaya (Nick) Matsumaru, General Manager, Catalent Shiga

The Asia-Pacific (APAC) region has become an emerging market for innovation in pharmaceuticals and biotechnology, including clinical research. Managing clinical supply distribution strategies within APAC can be very complex due to regulatory differences between countries and significant variations in weather and climate across the region. Maintaining business continuity while executing supply chain planning is crucial for the success of trials. Catalent's Daniel Gao and Tracey Clare will discuss the challenges and solutions related to the supply of investigational drugs within APAC.

<Webinar Title> Planning Ahead: Using Phase 2 to Anticipate Phase 3 Clinical Supply Challenges and Solutions In Phase 2 clinical trials, it is important for sponsors to prepare for potential challenges that may arise in Phase 3. Understanding the available resources is key to being prepared before starting Phase 3. - What are some challenges that sponsors may face in Phase 3? - How can sponsors strengthen research protocols and improve supply chain efficiency? - How can sponsors mitigate risks and ensure smooth study execution and accurate data collection? Please join this webinar to explore strategies for effective clinical trial supply management.

<Webinar Title> Planning Ahead: Using Phase 1 to Anticipate Phase 2 Clinical Supply Challenges and Solutions Typically, early-stage clinical research is not more complex than late-stage clinical research, but for long-term clinical trials, there are many important details to consider when selecting a clinical supply partner. For example, ensuring a "smooth transition from Phase 1 to Phase 2" can be achieved by utilizing a comprehensive solution with a single provider. What do clinical sponsors need to know about evaluating comprehensive solutions and potential providers? What are the challenges? What is the importance of strengthening partnerships to ensure success in the early stages? Join us for this webinar to explore strategies for effective clinical trial supply management.

Catalent provides flexible and creative solutions even for the most complex challenges of blinding and masking. In this article, expert Paul Ingram outlines how to ensure success by balancing strategy and adaptability while minimizing the risk of bias in research.

In this webinar, you will hear from Dennis Klone, Vice President of Quality at Catalent, and Ann McMahon, Program Director of Clinical Supply Services and Pharmaceutical Technology Integration, about avoiding issues and successful strategies from manufacturing to distribution in gene therapy. We hope you will join us!

An experienced clinical supply chain manager proposes ways to develop more efficient clinical supply plans, minimize risks, and advance research on schedule and within budget.

February 11, 2021 (Thursday) Time: 3:00 p.m. GMT This webinar, co-hosted with Bionow, will discuss how formulation selection can shape the future decisions of product development and the trajectory of projects, as well as propose ways to streamline product development, reduce the risk of delays, and shorten time to clinical trials by collaborating with a single integrated provider. Presentation 1: The Concept of Rapid Product Development Get from Concept to Clinic Faster on the Product Development Superhighway Stephen Tindal, Director, Science & Technology, Catalent Presentation 2: Optimizing Clinical Study Management Optimizing Clinical Study Management Gavin Yates, Program Director, Clinical Supply Services & Drug Product Technologies Integrations, Catalent

Supply planning and forecasting provide the greatest benefits in mitigating the risks of future clinical supply chain challenges. This ebook will introduce how these strategies can overcome unexpected supply-related issues and ensure optimal supply for patients.